Search results
Aug 8, 2023 · Eli Lilly on Tuesday raised its annual forecasts as demand for new diabetes drug Mounjaro surges ahead of a decision on its use as a weight-loss treatment, with shares soaring 18% to a record high ...
Lilly unites caring with discovery to create medicines that make life better for people around the world
Eli Lilly and Company will never ask for money in exchange of employment prospects or investment opportunities. If you encounter such requests, do not provide any information and report it on www.cybercrime.gov.in.
Eli Lilly and Company will never ask for money in exchange of employment prospects or investment opportunities. If you encounter such requests, do not provide any information and report it on www.cybercrime.gov.in.
Eli Lilly and Company works tirelessly to develop and deliver trusted medicines that meet real needs. These include Trulicity, Humalog, Alimta, Forteo, Taltz, Humulin, Basaglar, Jardiance, Cyramza, REYVOW, Verzenio, Emgality and more.
Acquisition to expand Lilly's immunology pipeline with oral integrin therapies INDIANAPOLIS and WALTHAM, Mass. , July 8, 2024 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) and Morphic Holding, Inc. (NASDAQ: MORF) today announced a definitive agreement for Lilly to acquire Morphic , a
Descoperirea de noi medicamente care îmbunătățesc viața pacienților. Valorile fundamentale ale Eli Lilly and Company – integritatea, excelența și respectul față de oameni – ne îndrumă în orice activitate.
